Using the islet perifusion preparation and the isolated rat pancreas in situ perfusion preparation, the effects of disopyramide (Diso) on insulin secretion were studied. In an isolated pancreatic islet perifusion experiment, Diso (300 pg/m0 produced a significant increase in the immunoreactive insulin (IRI) level in the perifusate. The Diso-induced IRI rise was not affected by pretreatment with various autonomic blocking agents, such as propranolol, phentolamine or atropine. In an isolated rat pancreas in situ perfusion experiment, the IRI level in the perfusate increased significantly after the administration of Diso (300 , ug/0.1 ml) under the perfusion of Krebs-Ringer bicarbonate buffer solution containing 0.3% glucose (0.3% glucose buffer) , but not under the perfusion of Krebs-Ringer bicarbonate buffer solution containing 0.1% glucose (0.1% glucose buffer) . The Diso-induced IRI rise was not affected by pretreatment with the autonomic blocking agents.
Fig. 1 Effects of disopyramide
A) and glucose (B) on insulin secretion in the pancreatic islet perifusion system. Table 1 Influences of disopyramide on insulin secretion and of the pretreatment of some autonomic blocking agents on disopyramide-induced insulin secretion during the perfusion of Krebs-Ringer bicarbonate buffer solution containing 0.3% glucose in in situ perfusion of rat pancreas 
